重组卡介苗载体系统的开发与分析 - Suppr

Suppr

超能文献

Development and analysis of recombinant BCG vector systems.

作者信息

Fuerst T R, de la Cruz V F, Bansal G P, Stover C K

机构信息

Department of Molecular Genetics, MedImmune, Inc., Gaithersburg, MD 20878.

出版信息

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1451-5. doi: 10.1089/aid.1992.8.1451.

DOI:10.1089/aid.1992.8.1451

PMID:1466980

Abstract

摘要

相似文献

Development and analysis of recombinant BCG vector systems.重组卡介苗载体系统的开发与分析

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1451-5. doi: 10.1089/aid.1992.8.1451.

Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.卡介苗作为一种活重组载体系统的开发：作为HIV疫苗的潜在用途。

Biotechnol Ther. 1991;2(1-2):159-78.

Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1449. doi: 10.1089/aid.1992.8.1449.

Humoral immunity to HIV, SIV, and SHIV.对HIV、SIV和SHIV的体液免疫

AIDS. 1998;12 Suppl A:S121-32.

DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.表达与C3d融合的可溶性CD4包膜蛋白的DNA疫苗可引发针对HIV-1的交叉反应性中和抗体。

Virology. 2004 Oct 25;328(2):292-300. doi: 10.1016/j.virol.2004.07.031.

Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.一种表达高免疫原性Gag p17/p24和Pol p51抗原的G/P-92融合蛋白增强了对1型人类免疫缺陷病毒Gag和Pol的细胞免疫和体液免疫反应。

J Hum Virol. 2001 Nov-Dec;4(6):306-16.

Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.用重组卡介苗（Mycobacterium bovis bacillus Calmette-Guérin）Env V3免疫恒河猴，可引发中和抗体介导的针对猿猴-人类免疫缺陷病毒的保护作用，该保护作用针对具有同源而非异源V3基序的病毒。

J Virol. 2005 Feb;79(3):1452-62. doi: 10.1128/JVI.79.3.1452-1462.2005.

Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.一种用于1型人类免疫缺陷病毒的重组卡介苗载体候选疫苗分泌的嵌合可溶性蛋白在小动物中诱导的保护性免疫反应。

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10693-7. doi: 10.1073/pnas.92.23.10693.

A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routes.一种表达猴免疫缺陷病毒（SIV）Nef、Env和Gag抗原的牛分枝杆菌卡介苗（Mycobacterium bovis BCG）重组体混合物，在通过不同黏膜途径接种疫苗的小鼠中诱导抗体和细胞毒性反应。

AIDS Res Hum Retroviruses. 1998 Dec 20;14(18):1625-33. doi: 10.1089/aid.1998.14.1625.

Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.利用嵌合gag-env病毒样颗粒开发艾滋病毒/艾滋病疫苗。

Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047.

引用本文的文献

Lung imaging characteristics in a patient infected with following cerebral hemorrhage surgery: A case report.脑出血手术后感染患者的肺部影像学特征：一例报告。

World J Clin Cases. 2024 Jan 6;12(1):169-175. doi: 10.12998/wjcc.v12.i1.169.

New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters.新型重组牛分枝杆菌卡介苗表达载体：加强对分枝杆菌启动子的基因控制

Appl Environ Microbiol. 2016 Apr 4;82(8):2240-2246. doi: 10.1128/AEM.03677-15. Print 2016 Apr.

Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.重组牛分枝杆菌卡介苗作为一种HIV疫苗载体。

Curr HIV Res. 2010 Jun;8(4):282-98. doi: 10.2174/157016210791208686.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验